AMA: FDA action on OTC naloxone will save people from overdoses
The AMA applauds the FDA and Commissioner Gottlieb for action to provide labeling that would allow for OTC availability of naloxone.
Study of Colorado’s Efforts to Reverse Opioid Epidemic
The AMA, Colorado Medical Society and Manatt Health release study of Colorado’s meaningful efforts to reverse the opioid epidemic.
Study of Pennsylvania commonwealth efforts to reverse opioid epidemic
AMA, Pennsylvania Medical Society and Manatt Health release analysis of progress made, recommend next steps for policymakers, insurers and physicians.
5 reasons to read the surgeon general’s opioid epidemic report
The AMA calls on the nation’s physicians to read this timely new report from the U.S. surgeon general. Find out what you will learn from America’s top doctor.
Naloxone: 5 tips on talking with patients, families
Be ready to answer your patients’ questions about naloxone, respond to resistance and reduce lingering stigma. Here’s how to talk with patients about this difficult topic.
Opioid-use disorder: Treat the family, not just the patient
Involving loved ones can help them cope and understand what effective treatment looks like. Learn more about family opioid treatment.
Physicians are fighting on the front lines of the opioid crisis
Physicians are fighting the opioid crisis through responsible opioid prescribing and grassroots programs tailored to their communities.
How to administer Naloxone
Learn how to use naloxone to save the life of someone suffering an opioid overdose.
AMA to bolster education for patients with opioid-use disorder
With opioid overdose deaths still on the rise, physicians call for improved patient education, and for naloxone to be included in airplane medical kits.